PHK
SLDB icon

Point72 Hong Kong’s Solid Biosciences SLDB Stock Holding History

Point72 Hong Kong’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-236
Closed -$13K – 2396
2021
Q2 		$13K Buy
236
+92
+64% +$6.08K ﹤0.01% 1707
2021
Q1 		$12K Buy
+144
New +$15.9K ﹤0.01% 1569

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Hong Kong's SLDB Position: Q3 2021 in Review

Point72 Hong Kong sold out of Solid Biosciences (SLDB) in Q3 2021, closing a stake of 236 shares — an estimated $13K sold.

Point72 Hong Kong first reported a position in SLDB in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q2 2021. 91 funds tracked by Wall St. Rank hold SLDB as of Q3 2021.

  • Point72 Hong Kong reported no remaining Solid Biosciences position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 236 Solid Biosciences shares in Q3 2021, an estimated $13K.
  • Point72 Hong Kong first reported a position in Solid Biosciences in Q1 2021 and held it in 2 quarters.
  • Point72 Hong Kong's Solid Biosciences position peaked at $13K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.